Cindy Tahl is CLO & Secretary at FATE THERAPEUTICS INC (FATE). They have made 26 open-market trades across 1 company since 2017, most recently 2026-08-04.
CIK 0001655472
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 26 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FATE | 589,355 | $1.0M |
Shares reported on the most recent Form 4, priced at the 2026-08-05 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FATE | SELL | 2026-08-04 | 2026-08-05 | $2.46 | $95K | -0.2% | -5.7% | — |
| FATE | SELL | 2026-05-20 | 2026-05-21 | $1.88 | $48K | +3.3% | +0.5% | +24.6% |
| FATE | SELL | 2026-01-09 | 2026-01-12 | $1.06 | $11K | +13.1% | +9.3% | +22.9% |
| FATE | SELL | 2025-08-04 | 2025-08-05 | $1.06 | $10K | +0.9% | -9.9% | +16.7% |
| FATE | SELL | 2025-01-10 | 2025-01-13 | $1.55 | $9K | +1.5% | -4.6% | -29.4% |
| FATE | SELL | 2024-01-09 | 2024-01-10 | $4.37 | $48K | +7.6% | +40.1% | +50.6% |
| FATE | SELL · 10b5-1 | 2023-11-09 | 2023-11-13 | $2.40 | $117K | +10.3% | +25.2% | +220.6% |
| FATE | SELL | 2023-01-10 | 2023-01-11 | $5.24 | $121K | -5.2% | +8.6% | -1.6% |
| FATE | SELL | 2022-06-01 | 2022-06-02 | $22.96 | $574K | -17.3% | +29.2% | +16.0% |
| FATE | SELL | 2022-04-01 | 2022-04-04 | $38.85 | $971K | -10.0% | -26.9% | -30.7% |
| FATE | SELL | 2022-01-11 | 2022-01-13 | $48.50 | $500K | -5.3% | -12.2% | -6.1% |
| FATE | SELL | 2022-01-10 | 2022-01-12 | $46.40 | $688K | -11.0% | -15.6% | -17.5% |
| FATE | SELL | 2022-01-03 | 2022-01-04 | $59.44 | $4.9M | -21.7% | -31.5% | -23.3% |
| FATE | SELL | 2021-10-01 | 2021-10-04 | $58.83 | $5.9M | +9.6% | +5.9% | +5.7% |
| FATE | SELL | 2021-07-01 | 2021-07-02 | $85.64 | $5.1M | -17.4% | -8.3% | -36.1% |
| FATE | SELL | 2021-04-01 | 2021-04-02 | $83.85 | $4.4M | +1.6% | +2.1% | +13.1% |
| FATE | SELL | 2021-01-19 | 2021-01-21 | $114.75 | $8.0M | -0.4% | +3.2% | -13.9% |
| FATE | SELL | 2021-01-08 | 2021-01-12 | $114.75 | $1.7M | -15.1% | -9.5% | -33.8% |
| FATE | SELL | 2020-11-04 | 2020-11-06 | $50.46 | $7.0M | +0.6% | +69.5% | +107.7% |
| FATE | SELL | 2020-10-16 | 2020-10-20 | $50.25 | $2.9M | -7.5% | +3.6% | +138.2% |
| FATE | SELL | 2020-10-01 | 2020-10-02 | $40.75 | $2.9M | +22.3% | +14.5% | +136.9% |
| FATE | SELL | 2020-01-08 | 2020-01-10 | $20.72 | $118K | +13.5% | +22.1% | +24.4% |
| FATE | SELL | 2019-10-15 | 2019-10-16 | $14.24 | $145K | +5.4% | +1.0% | +66.9% |
| FATE | SELL | 2019-03-01 | 2019-03-05 | $16.15 | $808K | +15.1% | +11.6% | +19.8% |
| FATE | SELL | 2019-02-25 | 2019-02-27 | $16.07 | $402K | +2.7% | +8.9% | +25.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.